Core Viewpoint - Buxton Helmsley USA, Inc. has released an open letter to Baker Tilly US, LLP regarding governance concerns at Daily Journal Corporation, indicating intentions to accumulate an interest in DJCO common stock in the future [1][5]. Group 1: Company Overview - Buxton Helmsley USA, Inc. is recognized as one of the top 15% activist investors globally, based on the number of investor advocacy campaigns [1]. - The firm engages in both active and passive investment strategies across various asset classes, focusing on opportunities in North America and Europe [5]. Group 2: Shareholder Communication - DJCO shareholders are encouraged to contact Buxton Helmsley via email for discussions related to the open letter [2]. - The firm may refrain from discussing certain aspects of the letter to avoid establishing an investor group under Section 13(d) of the Securities Exchange Act of 1934 [2]. Group 3: Media Engagement - Buxton Helmsley is open to interviews with media members to discuss governance concerns and their vision for restoring equity value at DJCO [3].

Group 1 - The focus has shifted towards offshore drilling, supply industry, and shipping, including tankers, containers, and dry bulk [1] - The fuel cell industry is being monitored as it is still in its early stages of development [1] Group 2 - The individual has extensive experience in navigating significant market events such as the dotcom bubble, the aftermath of the World Trade Center attacks, and the subprime crisis [2] - The individual has a background in auditing with PricewaterhouseCoopers before transitioning to day trading [2]

Core Viewpoint - Quantum BioPharma Ltd. announces the hiring of MNP LLP for PCAOB audits of Unbuzzd Wellness Inc. in preparation for a potential IPO, following the resignation of the previous auditor [1][2][3] Group 1: Company Developments - Unbuzzd Wellness Inc. has engaged MNP LLP to conduct PCAOB audits effective May 20, 2025, to ensure compliance and readiness for a possible IPO [1][2] - The company has changed its name to Unbuzzd Wellness Inc. effective May 23, 2025, with new CUSIP and ISIN numbers assigned [4][5] - There were no reservations or modified opinions in the previous auditor's reports, indicating a clean audit history [3] Group 2: Product Information - Unbuzzd is a scientifically-proven beverage designed to accelerate alcohol metabolism, restore mental clarity, and reduce hangover symptoms, appealing to a broad audience of alcohol consumers [8][9] - The product has been validated by a double-blind, randomized, placebo-controlled clinical trial, demonstrating its effectiveness in speeding up alcohol metabolism and reducing symptoms of intoxication [9] Group 3: Leadership Insights - John Duffy, CEO of Unbuzzd Wellness Inc., emphasizes the importance of MNP's engagement in adhering to industry standards and preparing for the IPO [3] - Gerry David, Board Co-Chair, highlights the completion of PCAOB audits as a crucial step in raising capital and considering an IPO [3] Group 4: Ownership and Financial Structure - Quantum BioPharma retains a 20.11% ownership stake in Unbuzzd Wellness Inc. and is entitled to 7% royalty payments from sales until reaching $250 million, after which the royalty rate will drop to 3% [6]